These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 9256312)
1. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Borba EF; Bonfá E Lupus; 1997; 6(6):533-9. PubMed ID: 9256312 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of dyslipoproteinemias in systemic lupus erythematosus. Borba EF; Carvalho JF; Bonfá E Clin Dev Immunol; 2006; 13(2-4):203-8. PubMed ID: 17162363 [TBL] [Abstract][Full Text] [Related]
3. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome]. Sarzi-Puttini P; Atzeni F; Carrabba M Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154 [TBL] [Abstract][Full Text] [Related]
4. Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus. Lahita RG; Rivkin E; Cavanagh I; Romano P Arthritis Rheum; 1993 Nov; 36(11):1566-74. PubMed ID: 8240433 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of traditional cardiovascular risk factors in patients with systemic lupus erythematosus]. Liu L; Zhang T; Ye Y; Zhang S; Chen L Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):753-8. PubMed ID: 25511096 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of dyslipoproteinemia in Thai patients with systemic lupus erythematosus. Siripaitoon B; Osiri M; Vongthavaravat V; Akkasilpa S; Deesomchok U Lupus; 2004; 13(12):961-8. PubMed ID: 15645754 [TBL] [Abstract][Full Text] [Related]
8. Dysregulated serum lipid profile and its correlation to disease activity in young female adults diagnosed with systemic lupus erythematosus: a cross-sectional study. Zhou B; Xia Y; She J Lipids Health Dis; 2020 Mar; 19(1):40. PubMed ID: 32171306 [TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928 [TBL] [Abstract][Full Text] [Related]
11. [Echocardiographic changes and anticardiolipin antibodies in patients with systemic lupus erythematosus]. Zhang SD; Wu M; Chen F; Zuo XX; Zhang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):692-5. PubMed ID: 17062932 [TBL] [Abstract][Full Text] [Related]
12. Dyslipoproteinemia during the active course of systemic lupus erythematosus in association with anti-double-stranded DNA (anti-dsDNA) antibodies. Kashef S; Ghaedian MM; Rajaee A; Ghaderi A Rheumatol Int; 2007 Jan; 27(3):235-41. PubMed ID: 16944155 [TBL] [Abstract][Full Text] [Related]
13. Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids. Ettinger WH; Goldberg AP; Applebaum-Bowden D; Hazzard WR Am J Med; 1987 Sep; 83(3):503-8. PubMed ID: 3661587 [TBL] [Abstract][Full Text] [Related]
14. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371 [TBL] [Abstract][Full Text] [Related]
15. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259 [TBL] [Abstract][Full Text] [Related]
16. Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: a prospective study. Urquizu-Padilla M; Balada E; Chacon P; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J J Rheumatol; 2009 Aug; 36(8):1639-45. PubMed ID: 19531751 [TBL] [Abstract][Full Text] [Related]
17. Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients. Formiga F; Meco JF; Pinto X; Jacob J; Moga I; Pujol R Lupus; 2001; 10(5):359-63. PubMed ID: 11403267 [TBL] [Abstract][Full Text] [Related]
18. Lipid profile and anticardiolipin antibodies in Behcet's disease. Musabak U; Baylan O; Cetin T; Yesilova Z; Sengul A; Saglam K; Inal A; Kocar IH Arch Med Res; 2005; 36(4):387-92. PubMed ID: 15950080 [TBL] [Abstract][Full Text] [Related]
19. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
20. Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations. Ortiz TT; Terreri MT; Caetano M; Souza FS; D'Almeida V; Sarni RO; Hilário MO Ann Nutr Metab; 2013; 63(1-2):77-82. PubMed ID: 23942034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]